1
|
Carnegie L, McCrone JT, du Plessis L, Hasan M, Ali MZ, Begum R, Hassan MZ, Islam S, Rahman MH, Uddin ASM, Sarker MS, Das T, Hossain M, Khan M, Razu MH, Akram A, Arina S, Hoque E, Molla MMA, Nafisaa T, Angra P, Rambaut A, Pullan ST, Osman KL, Hoque MA, Biswas P, Flora MS, Raghwani J, Fournié G, Samad MA, Hill SC. Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh. Virol J 2024; 21:291. [PMID: 39538264 PMCID: PMC11562509 DOI: 10.1186/s12985-024-02560-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 10/26/2024] [Indexed: 11/16/2024] Open
Abstract
BACKGROUND Genomic epidemiology has helped reconstruct the global and regional movement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is still a lack of understanding of SARS-CoV-2 spread in some of the world's least developed countries (LDCs). METHODS To begin to address this disparity, we studied the transmission dynamics of the virus in Bangladesh during the country's first COVID-19 wave by analysing case reports and whole-genome sequences from all eight divisions of the country. RESULTS We detected > 50 virus introductions to the country during the period, including during a period of national lockdown. Additionally, through discrete phylogeographic analyses, we identified that geographical distance and population -density and/or -size influenced virus spatial dispersal in Bangladesh. CONCLUSIONS Overall, this study expands our knowledge of SARS-CoV-2 genomic epidemiology in Bangladesh, shedding light on crucial transmission characteristics within the country, while also acknowledging resemblances and differences to patterns observed in other nations.
Collapse
Affiliation(s)
- L Carnegie
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK.
| | - J T McCrone
- Institute of Ecology and Evolution, University of Edinburgh, King's Buildings, Edinburgh, UK
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - L du Plessis
- Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - M Hasan
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M Z Ali
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - R Begum
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M Z Hassan
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - S Islam
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
- Global Change Center, Virginia Tech, Blacksburg, VA, USA
| | - M H Rahman
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - A S M Uddin
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M S Sarker
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - T Das
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
- School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - M Hossain
- NSU Genome Research Institute (NGRI), North South University, Bashundhara, Dhaka, Bangladesh
- Department of Biochemistry and Microbiology, North South University, Bashundhara, Dhaka, Bangladesh
| | - M Khan
- Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhanmondi, Dhaka, Bangladesh
| | - M H Razu
- Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhanmondi, Dhaka, Bangladesh
| | - A Akram
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - S Arina
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - E Hoque
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - M M A Molla
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - T Nafisaa
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - P Angra
- Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - A Rambaut
- Institute of Ecology and Evolution, University of Edinburgh, King's Buildings, Edinburgh, UK
| | - S T Pullan
- United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK
| | - K L Osman
- United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK
| | - M A Hoque
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
| | - P Biswas
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
| | - M S Flora
- National Institute of Preventive and Social Medicine (NIPSOM), Ministry of Health and Family Welfare, Dhaka, Bangladesh
| | - J Raghwani
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK
| | - G Fournié
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK
- Université de Lyon, INRAE, VetAgro Sup, UMR EPIA, Marcy l'Etoile, France
- Université Clermont Auvergne, INRAE, VetAgro Sup, UMR EPIA, Saint Genes Champanelle, France
| | - M A Samad
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh.
| | - S C Hill
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK.
| |
Collapse
|
2
|
Gutierrez B, Tsui JLH, Pullano G, Mazzoli M, Gangavarapu K, Inward RPD, Bajaj S, Evans Pena R, Busch-Moreno S, Suchard MA, Pybus OG, Dunner A, Puentes R, Ayala S, Fernandez J, Araos R, Ferres L, Colizza V, Kraemer MUG. Routes of importation and spatial dynamics of SARS-CoV-2 variants during localized interventions in Chile. PNAS NEXUS 2024; 3:pgae483. [PMID: 39525554 PMCID: PMC11547135 DOI: 10.1093/pnasnexus/pgae483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 08/27/2024] [Indexed: 11/16/2024]
Abstract
Human mobility is strongly associated with the spread of SARS-CoV-2 via air travel on an international scale and with population mixing and the number of people moving between locations on a local scale. However, these conclusions are drawn mostly from observations in the context of the global north where international and domestic connectivity is heavily influenced by the air travel network; scenarios where land-based mobility can also dominate viral spread remain understudied. Furthermore, research on the effects of nonpharmaceutical interventions (NPIs) has mostly focused on national- or regional-scale implementations, leaving gaps in our understanding of the potential benefits of implementing NPIs at higher granularity. Here, we use Chile as a model to explore the role of human mobility on disease spread within the global south; the country implemented a systematic genomic surveillance program and NPIs at a very high spatial granularity. We combine viral genomic data, anonymized human mobility data from mobile phones and official records of international travelers entering the country to characterize the routes of importation of different variants, the relative contributions of airport and land border importations, and the real-time impact of the country's mobility network on the diffusion of SARS-CoV-2. The introduction of variants which are dominant in neighboring countries (and not detected through airport genomic surveillance) is predicted by land border crossings and not by air travelers, and the strength of connectivity between comunas (Chile's lowest administrative divisions) predicts the time of arrival of imported lineages to new locations. A higher stringency of local NPIs was also associated with fewer domestic viral importations. Our analysis sheds light on the drivers of emerging respiratory infectious disease spread outside of air travel and on the consequences of disrupting regular movement patterns at lower spatial scales.
Collapse
Affiliation(s)
- Bernardo Gutierrez
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
- Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito USFQ, Quito 170901, Ecuador
| | - Joseph L -H Tsui
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Giulia Pullano
- Department of Biology, Georgetown University, Washington, DC 20057, USA
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
| | - Mattia Mazzoli
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
- ISI Foundation, 10126 Turin, Italy
| | - Karthik Gangavarapu
- Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Rhys P D Inward
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Sumali Bajaj
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Rosario Evans Pena
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Simon Busch-Moreno
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Marc A Suchard
- Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA
- Department of Biostatistics, University of California Los Angeles, Los Angeles, CA 90095, USA
- Department of Biomathematics, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Oliver G Pybus
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
- Department of Pathobiology and Population Science, Royal Veterinary College, London AL9 7TA, United Kingdom
| | | | - Rodrigo Puentes
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Salvador Ayala
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Jorge Fernandez
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Rafael Araos
- Facultad de Medicina Clínica Alemana, Instituto de Ciencias e Innovación en Medicina (ICIM), Universidad del Desarrollo, 7610671 Santiago, Chile
| | - Leo Ferres
- ISI Foundation, 10126 Turin, Italy
- Data Science Institute, Universidad del Desarrollo, 7610671 Santiago, Chile
- Telefónica, 7500775 Santiago, Chile
| | - Vittoria Colizza
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
- Tokyo Tech World Research Hub Initiative, Institute of Innovative Research, Tokyo Institute of Technology, Tokyo 152-8550, Japan
| | - Moritz U G Kraemer
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
| |
Collapse
|
3
|
Andrade-Molina DA, Morey-León GA, Muñoz-Mawyin KE, Cruz-Fatuly FF, Fernández-Cadena JC, Cárdenas P. First sequenced cases of Omicron BA.2 sublineage in Ecuador. Virus Res 2023; 334:199169. [PMID: 37406934 PMCID: PMC10410591 DOI: 10.1016/j.virusres.2023.199169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2022] [Revised: 07/01/2023] [Accepted: 07/02/2023] [Indexed: 07/07/2023]
Abstract
The largest wave of infection with SARS-CoV-2 virus in Ecuador was observed in mid-December 2021 and early January 2022, driven by B.1.1.529/BA (Omicron) variant. During the second half of March, an increase in the number of daily cases was observed and coincided with the emergence of the BA.2 variant, which we describe in the present study. The first sequenced five cases of SARS-CoV-2 21L/BA.2 in Ecuador were identified using variant specific genotyping by qPCR and confirmed by whole genome sequencing (WGS). The first sequenced Ecuadorian BA.2 isolate was obtained from a person with international travel history who became symptomatic 3 days after travelling, whereas in the other cases no travel history was recorded.
Collapse
Affiliation(s)
- D A Andrade-Molina
- Omics Sciences Laboratory, Faculty of Health Sciences, Universidad Espíritu Santo, Samborondón, Ecuador.
| | - G A Morey-León
- Faculty of Health Sciences, Universidad de Guayaquil, Guayaquil, Ecuador
| | - K E Muñoz-Mawyin
- Omics Sciences Laboratory, Faculty of Health Sciences, Universidad Espíritu Santo, Samborondón, Ecuador
| | - F F Cruz-Fatuly
- Omics Sciences Laboratory, Faculty of Health Sciences, Universidad Espíritu Santo, Samborondón, Ecuador
| | | | - P Cárdenas
- Institute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador
| |
Collapse
|
4
|
Castelán-Sánchez HG, Delaye L, Inward RPD, Dellicour S, Gutierrez B, Martinez de la Vina N, Boukadida C, Pybus OG, de Anda Jáuregui G, Guzmán P, Flores-Garrido M, Fontanelli Ó, Hernández Rosales M, Meneses A, Olmedo-Alvarez G, Herrera-Estrella AH, Sánchez-Flores A, Muñoz-Medina JE, Comas-García A, Gómez-Gil B, Zárate S, Taboada B, López S, Arias CF, Kraemer MUG, Lazcano A, Escalera Zamudio M. Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico. eLife 2023; 12:e82069. [PMID: 37498057 PMCID: PMC10431917 DOI: 10.7554/elife.82069] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Accepted: 07/23/2023] [Indexed: 07/28/2023] Open
Abstract
Over 200 different SARS-CoV-2 lineages have been observed in Mexico by November 2021. To investigate lineage replacement dynamics, we applied a phylodynamic approach and explored the evolutionary trajectories of five dominant lineages that circulated during the first year of local transmission. For most lineages, peaks in sampling frequencies coincided with different epidemiological waves of infection in Mexico. Lineages B.1.1.222 and B.1.1.519 exhibited similar dynamics, constituting clades that likely originated in Mexico and persisted for >12 months. Lineages B.1.1.7, P.1 and B.1.617.2 also displayed similar dynamics, characterized by multiple introduction events leading to a few successful extended local transmission chains that persisted for several months. For the largest B.1.617.2 clades, we further explored viral lineage movements across Mexico. Many clades were located within the south region of the country, suggesting that this area played a key role in the spread of SARS-CoV-2 in Mexico.
Collapse
Affiliation(s)
- Hugo G Castelán-Sánchez
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Programa de Investigadoras e Investigadores por México, Consejo Nacional de Ciencia y TecnologíaMexico CityMexico
| | - Luis Delaye
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Ingeniería Genética, CINVESTAV-Unidad IrapuatoGuanajuatoMexico
| | - Rhys PD Inward
- Department of Biology, University of OxfordOxfordUnited Kingdom
| | - Simon Dellicour
- Spatial Epidemiology Lab (SpELL), Université Libre de BruxellesBruxellesBelgium
- Department of Microbiology, Immunology and Transplantation, Rega Institute, KU LeuvenLeuvenBelgium
| | - Bernardo Gutierrez
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Department of Biology, University of OxfordOxfordUnited Kingdom
| | | | - Celia Boukadida
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades RespiratoriasMexico CityMexico
| | - Oliver G Pybus
- Department of Biology, University of OxfordOxfordUnited Kingdom
- Department of Pathobiology, Royal Veterinary CollegeLondonUnited Kingdom
| | - Guillermo de Anda Jáuregui
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Programa de Investigadoras e Investigadores por México, Consejo Nacional de Ciencia y TecnologíaMexico CityMexico
- Instituto Nacional de Medicina GenómicaMexico CityMexico
| | | | - Marisol Flores-Garrido
- Escuela Nacional de Estudios Superiores, Universidad Nacional Autónoma de MéxicoMexico CityMexico
- Departamento de Ciencias de la Computación, CINVESTAV-IPNMexico CityMexico
| | - Óscar Fontanelli
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Ingeniería Genética, CINVESTAV-Unidad IrapuatoGuanajuatoMexico
| | - Maribel Hernández Rosales
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Ingeniería Genética, CINVESTAV-Unidad IrapuatoGuanajuatoMexico
| | - Amilcar Meneses
- Escuela Nacional de Estudios Superiores, Universidad Nacional Autónoma de MéxicoMexico CityMexico
- Departamento de Ciencias de la Computación, CINVESTAV-IPNMexico CityMexico
| | - Gabriela Olmedo-Alvarez
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Ingeniería Genética, CINVESTAV-Unidad IrapuatoGuanajuatoMexico
| | - Alfredo Heriberto Herrera-Estrella
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Laboratorio de expresión génica y desarrollo en hongos, CINVESTAV-Unidad IrapuatoIrapuatoMexico
| | - Alejandro Sánchez-Flores
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Unidad Universitaria de Secuenciación Masiva y Bioinformática, Instituto de Biotecnología, Universidad Nacional Autónoma de MéxicoChamilpaMexico
| | - José Esteban Muñoz-Medina
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro SocialMexico CityMexico
| | - Andreu Comas-García
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Facultad de Medicina y Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis PotosíSan Luis PotosíMexico
| | - Bruno Gómez-Gil
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Centro de Investigación en Alimentación y Desarrollo-CIAD, Unidad Regional Mazatlán en Acuicultura y Manejo AmbientalSinaloaMexico
| | - Selene Zárate
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de MéxicoMexico CityMexico
| | - Blanca Taboada
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Genética del Desarrollo y Fisiología Molecular, Universidad Nacional Autónoma de MéxicoCuernavacaMexico
| | - Susana López
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Genética del Desarrollo y Fisiología Molecular, Universidad Nacional Autónoma de MéxicoCuernavacaMexico
| | - Carlos F Arias
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Departamento de Genética del Desarrollo y Fisiología Molecular, Universidad Nacional Autónoma de MéxicoCuernavacaMexico
| | - Moritz UG Kraemer
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Department of Biology, University of OxfordOxfordUnited Kingdom
| | - Antonio Lazcano
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Facultad de Ciencias, Universidad Nacional Autónoma de MéxicMexico CityMexico
| | - Marina Escalera Zamudio
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex)Mexico CityMexico
- Department of Biology, University of OxfordOxfordUnited Kingdom
| |
Collapse
|
5
|
Sahadeo NSD, Nicholls S, Moreira FRR, O’Toole Á, Ramkissoon V, Whittaker C, Hill V, McCrone JT, Mohammed N, Ramjag A, Brown Jordan A, Hill SC, Singh R, Nathaniel-Girdharrie SM, Hinds A, Ramkissoon N, Parag KV, Nandram N, Parasram R, Khan-Mohammed Z, Edghill L, Indar L, Andrewin A, Sealey-Thomas R, McMillan P, Oyinloye A, George K, Potter I, Lee J, Johnson D, Charles S, Singh N, Bisesor-McKenzie J, Laws H, Belmar-George S, Keizer-Beache S, Greenaway-Duberry S, Ashwood N, Foster JE, Georges K, Naidu R, Ivey M, Giddings S, Haraksingh R, Ramsubhag A, Jayaraman J, Chinnadurai C, Oura C, Pybus OG, St. John J, Gonzalez-Escobar G, Faria NR, Carrington CVF. Implementation of genomic surveillance of SARS-CoV-2 in the Caribbean: Lessons learned for sustainability in resource-limited settings. PLOS GLOBAL PUBLIC HEALTH 2023; 3:e0001455. [PMID: 36963002 PMCID: PMC10022082 DOI: 10.1371/journal.pgph.0001455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Accepted: 01/26/2023] [Indexed: 02/24/2023]
Abstract
The COVID-19 pandemic highlighted the importance of global genomic surveillance to monitor the emergence and spread of SARS-CoV-2 variants and inform public health decision-making. Until December 2020 there was minimal capacity for viral genomic surveillance in most Caribbean countries. To overcome this constraint, the COVID-19: Infectious disease Molecular epidemiology for PAthogen Control & Tracking (COVID-19 IMPACT) project was implemented to establish rapid SARS-CoV-2 whole genome nanopore sequencing at The University of the West Indies (UWI) in Trinidad and Tobago (T&T) and provide needed SARS-CoV-2 sequencing services for T&T and other Caribbean Public Health Agency Member States (CMS). Using the Oxford Nanopore Technologies MinION sequencing platform and ARTIC network sequencing protocols and bioinformatics pipeline, a total of 3610 SARS-CoV-2 positive RNA samples, received from 17 CMS, were sequenced in-situ during the period December 5th 2020 to December 31st 2021. Ninety-one Pango lineages, including those of five variants of concern (VOC), were identified. Genetic analysis revealed at least 260 introductions to the CMS from other global regions. For each of the 17 CMS, the percentage of reported COVID-19 cases sequenced by the COVID-19 IMPACT laboratory ranged from 0·02% to 3·80% (median = 1·12%). Sequences submitted to GISAID by our study represented 73·3% of all SARS-CoV-2 sequences from the 17 CMS available on the database up to December 31st 2021. Increased staffing, process and infrastructural improvement over the course of the project helped reduce turnaround times for reporting to originating institutions and sequence uploads to GISAID. Insights from our genomic surveillance network in the Caribbean region directly influenced non-pharmaceutical countermeasures in the CMS countries. However, limited availability of associated surveillance and clinical data made it challenging to contextualise the observed SARS-CoV-2 diversity and evolution, highlighting the need for development of infrastructure for collecting and integrating genomic sequencing data and sample-associated metadata.
Collapse
Affiliation(s)
- Nikita S. D. Sahadeo
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Soren Nicholls
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Filipe R. R. Moreira
- MRC Centre for Global Infectious Disease Analysis, Department for Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
| | - Áine O’Toole
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
| | - Vernie Ramkissoon
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Charles Whittaker
- MRC Centre for Global Infectious Disease Analysis, Department for Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
| | - Verity Hill
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
| | - John T. McCrone
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
| | - Nicholas Mohammed
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Anushka Ramjag
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Arianne Brown Jordan
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Sarah C. Hill
- Department of Zoology, University of Oxford, Oxford, United Kingdom
- Department of Pathobiology and Population Sciences, The Royal Veterinary College, London, United Kingdom
| | - Risha Singh
- Caribbean Public Health Agency (CARPHA), Headquartered in Port of Spain, Republic of Trinidad and Tobago
| | | | - Avery Hinds
- Ministry of Health, Port of Spain, Republic of Trinidad and Tobago
| | - Nuala Ramkissoon
- Ministry of Health, Port of Spain, Republic of Trinidad and Tobago
| | - Kris V. Parag
- MRC Centre for Global Infectious Disease Analysis, Department for Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
| | - Naresh Nandram
- Ministry of Health, Port of Spain, Republic of Trinidad and Tobago
| | - Roshan Parasram
- Ministry of Health, Port of Spain, Republic of Trinidad and Tobago
| | | | - Lisa Edghill
- Caribbean Public Health Agency (CARPHA), Headquartered in Port of Spain, Republic of Trinidad and Tobago
| | - Lisa Indar
- Caribbean Public Health Agency (CARPHA), Headquartered in Port of Spain, Republic of Trinidad and Tobago
| | | | | | | | | | | | - Irad Potter
- Ministry of Health and Social Development, Road Town, Tortola, British Virgin Islands
| | - John Lee
- Ministry of Health and Wellness, George Town, Grand Cayman, Cayman Islands
| | - David Johnson
- Ministry of Health, Wellness and New Health Investment, Roseau, Dominica
| | | | | | | | - Hazel Laws
- Ministry of Health, Basseterre, Saint Kitts and Nevis
| | | | - Simone Keizer-Beache
- Ministry of Health, Wellness and the Environment, Kingstown, Saint Vincent and the Grenadines
| | | | - Nadia Ashwood
- Ministry of Health, Agriculture, Sports and Human Services, Grand Turk, Turks and Caicos Islands
| | - Jerome E. Foster
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Karla Georges
- School of Veterinary Medicine, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Rahul Naidu
- School of Dentistry, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Marsha Ivey
- Department of Clinical Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Stanley Giddings
- Department of Clinical Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Rajini Haraksingh
- Department of Life Sciences, Faculty of Sciences of Technology, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Adesh Ramsubhag
- Department of Life Sciences, Faculty of Sciences of Technology, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Jayaraj Jayaraman
- Department of Life Sciences, Faculty of Sciences of Technology, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Chinnaraja Chinnadurai
- Department of Life Sciences, Faculty of Sciences of Technology, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Christopher Oura
- School of Veterinary Medicine, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| | - Oliver G. Pybus
- Department of Zoology, University of Oxford, Oxford, United Kingdom
- Department of Pathobiology and Population Sciences, The Royal Veterinary College, London, United Kingdom
| | - Joy St. John
- Caribbean Public Health Agency (CARPHA), Headquartered in Port of Spain, Republic of Trinidad and Tobago
| | - Gabriel Gonzalez-Escobar
- Caribbean Public Health Agency (CARPHA), Headquartered in Port of Spain, Republic of Trinidad and Tobago
| | - Nuno R. Faria
- MRC Centre for Global Infectious Disease Analysis, Department for Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
| | - Christine V. F. Carrington
- Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago
| |
Collapse
|
6
|
de Menezes MT, Moreira FRR, Whittaker C, Santos FM, Queiroz DC, Geddes V, Fonseca PLC, de Jesus JG, Mendes-Oliveira F, Reis-Souza V, Santos B, Zauli DAG, de Lima AB, de Brito Mendonça C, Alvim LB, do Prado Silva J, Malta FSV, de Souza Ferreira AC, Faria NR, Sabino EC, Aguiar RS. Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil. Viruses 2023; 15:585. [PMID: 36851799 PMCID: PMC9962645 DOI: 10.3390/v15020585] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Revised: 01/21/2023] [Accepted: 01/24/2023] [Indexed: 02/22/2023] Open
Abstract
Brazil is one of the nations most affected by Coronavirus disease 2019 (COVID-19). The introduction and establishment of new virus variants can be related to an increase in cases and fatalities. The emergence of Omicron, the most modified SARS-CoV-2 variant, caused alarm for the public health of Brazil. In this study, we examined the effects of the Omicron introduction in Minas Gerais (MG), the second-most populous state of Brazil. A total of 430 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) samples from November 2021 to June 2022 from Belo Horizonte (BH) city were sequenced. These newly sequenced genomes comprise 72% of all previously available SARS-CoV-2 genomes for the city. Evolutionary analysis of novel viral genomes reveals that a great diversity of Omicron sublineages have circulated in BH, a pattern in-keeping with observations across Brazil more generally. Bayesian phylogeographic reconstructions indicate that this diversity is a product of a large number of international and national importations. As observed previously, São Paulo state is shown as a significant hub for viral spread throughout the country, contributing to around 70% of all viral Omicron introductions detected in MG.
Collapse
Affiliation(s)
- Mariane Talon de Menezes
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
| | - Filipe Romero Rebello Moreira
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
| | - Charles Whittaker
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
| | - Franciele Martins Santos
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Daniel Costa Queiroz
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Victor Geddes
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Paula Luize Camargos Fonseca
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Jaqueline Góes de Jesus
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Franciane Mendes-Oliveira
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Valquíria Reis-Souza
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | | | | | - Aline Brito de Lima
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | | | - Luige Biciati Alvim
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | - Joice do Prado Silva
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | | | | | - Nuno R. Faria
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Zoology, University of Oxford, Oxford OX3 7BN, UK
| | - Ester Cerdeira Sabino
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Renato Santana Aguiar
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
- D’OR Institute of Research and Teaching, Rio de Janeiro 21941-901, Brazil
| |
Collapse
|
7
|
Manna PR, Gray ZC, Sikdar M, Reddy H. COVID-19 and its genomic variants: Molecular pathogenesis and therapeutic interventions. EXCLI JOURNAL 2022; 21:1196-1221. [PMID: 36381644 PMCID: PMC9650701 DOI: 10.17179/excli2022-5315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Accepted: 09/05/2022] [Indexed: 11/25/2022]
Abstract
Coronavirus disease-19 (COVID-19), caused by a β-coronavirus and its genomic variants, is associated with substantial morbidities and mortalities globally. The COVID-19 virus and its genomic variants enter host cells upon binding to the angiotensin converting enzyme 2 receptors that are expressed in a variety of tissues, but predominantly in the lungs, heart, and blood vessels. Patients afflicted with COVID-19 may be asymptomatic or present with critical symptoms possibly due to diverse lifestyles, immune responses, aging, and underlying medical conditions. Geriatric populations, especially men in comparison to women, with immunocompromised conditions, are most vulnerable to severe COVID-19 associated infections, complications, and mortalities. Notably, whereas immunomodulation, involving nutritional consumption, is essential to protecting an individual from COVID-19, immunosuppression is detrimental to a person with this aggressive disease. As such, immune health is inversely correlated to COVID-19 severity and resulting consequences. Advances in genomic and proteomic technologies have helped us to understand the molecular events underlying symptomatology, transmission and, pathogenesis of COVID-19 and its genomic variants. Accordingly, there has been development of a variety of therapeutic interventions, ranging from mask wearing to vaccination to medication. This review summarizes the current understanding of molecular pathogenesis of COVID-19, effects of comorbidities on COVID-19, and prospective therapeutic strategies for the prevention and treatment of this contagious disease.
Collapse
Affiliation(s)
- Pulak R. Manna
- Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA,*To whom correspondence should be addressed: Pulak R. Manna, Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA; Tel: +1-806-743-3573, Fax: +1-806-743-3143, E-mail:
| | - Zackery C. Gray
- Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA
| | - Malabika Sikdar
- Department of Zoology, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, MP 470003, India
| | - Hemachandra Reddy
- Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA,Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA,Neurology, Departments of School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA,Public Health Department of the Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA,Department of Speech, Language and Hearing Sciences, School Health Professions, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA,Nutritional Sciences Department, College of Human Sciences, Texas Tech University, Lubbock, TX 79409, USA
| |
Collapse
|
8
|
Brizzi A, Whittaker C, Servo LMS, Hawryluk I, Prete CA, de Souza WM, Aguiar RS, Araujo LJT, Bastos LS, Blenkinsop A, Buss LF, Candido D, Castro MC, Costa SF, Croda J, de Souza Santos AA, Dye C, Flaxman S, Fonseca PLC, Geddes VEV, Gutierrez B, Lemey P, Levin AS, Mellan T, Bonfim DM, Miscouridou X, Mishra S, Monod M, Moreira FRR, Nelson B, Pereira RHM, Ranzani O, Schnekenberg RP, Semenova E, Sonabend R, Souza RP, Xi X, Sabino EC, Faria NR, Bhatt S, Ratmann O. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals. Nat Med 2022; 28:1476-1485. [PMID: 35538260 PMCID: PMC9307484 DOI: 10.1038/s41591-022-01807-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Accepted: 03/31/2022] [Indexed: 02/07/2023]
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Gamma variant of concern has spread rapidly across Brazil since late 2020, causing substantial infection and death waves. Here we used individual-level patient records after hospitalization with suspected or confirmed coronavirus disease 2019 (COVID-19) between 20 January 2020 and 26 July 2021 to document temporary, sweeping shocks in hospital fatality rates that followed the spread of Gamma across 14 state capitals, during which typically more than half of hospitalized patients aged 70 years and older died. We show that such extensive shocks in COVID-19 in-hospital fatality rates also existed before the detection of Gamma. Using a Bayesian fatality rate model, we found that the geographic and temporal fluctuations in Brazil's COVID-19 in-hospital fatality rates were primarily associated with geographic inequities and shortages in healthcare capacity. We estimate that approximately half of the COVID-19 deaths in hospitals in the 14 cities could have been avoided without pre-pandemic geographic inequities and without pandemic healthcare pressure. Our results suggest that investments in healthcare resources, healthcare optimization and pandemic preparedness are critical to minimize population-wide mortality and morbidity caused by highly transmissible and deadly pathogens such as SARS-CoV-2, especially in low- and middle-income countries.
Collapse
Affiliation(s)
- Andrea Brizzi
- Department of Mathematics, Imperial College London, London, UK
| | - Charles Whittaker
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
| | | | - Iwona Hawryluk
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
| | - Carlos A Prete
- Departamento de Engenharia de Sistemas Eletrônicos, Escola Politécnica, Universidade de São Paulo, São Paulo, Brazil
| | - William M de Souza
- World Reference Center for Emerging Viruses and Arboviruses and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston TX, USA
| | - Renato S Aguiar
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil
| | - Leonardo J T Araujo
- Laboratory of Quantitative Pathology, Center of Pathology, Adolfo Lutz Institute, São Paulo, Brazil
| | - Leonardo S Bastos
- Programa de Computação Científica, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | | | - Lewis F Buss
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
| | | | - Marcia C Castro
- Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston MA, USA
| | - Silvia F Costa
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
| | - Julio Croda
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven CT, USA
| | | | | | - Seth Flaxman
- Department of Computer Science, University of Oxford, Oxford, UK
| | - Paula L C Fonseca
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Victor E V Geddes
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | | | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven - University of Leuven, Leuven, Belgium
| | - Anna S Levin
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
| | - Thomas Mellan
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
| | - Diego M Bonfim
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | | | - Swapnil Mishra
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
- Section of Epidemiology, School of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Mélodie Monod
- Department of Mathematics, Imperial College London, London, UK
| | - Filipe R R Moreira
- Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Bruce Nelson
- Environmental Dynamics, INPA, National Institute for Amazon Research, Manaus, Brazil
| | | | - Otavio Ranzani
- Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
| | | | | | - Raphael Sonabend
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
| | - Renan P Souza
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Xiaoyue Xi
- Department of Mathematics, Imperial College London, London, UK
| | - Ester C Sabino
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
| | - Nuno R Faria
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
- Departamento de Moléstias Infecciosas e Parasitárias e Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
- Department of Zoology, University of Oxford, Oxford, UK.
- Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
| | - Samir Bhatt
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
- Section of Epidemiology, School of Public Health, University of Copenhagen, Copenhagen, Denmark.
| | - Oliver Ratmann
- Department of Mathematics, Imperial College London, London, UK.
| |
Collapse
|
9
|
Fonseca PLC, Moreira FRR, de Souza RM, Guimarães NR, Carvalho NO, Adelino TER, Alves HJ, Alvim LB, Candido DS, Coelho HP, Costa AVB, Costa WC, de Carvalho AF, de Faria BWF, de Lima AB, de Oliveira ES, de Souza CSA, de Souza FG, Dias RC, Geddes VEV, Godinho IP, Gonçalves AL, Lourenço KL, Magalhães RDM, Malta FSV, Medeiros ELA, Mendes FS, Mendes PHBDP, Mendonça CPTB, Menezes AL, Menezes D, Menezes MT, Miguita L, Moreira RG, Peixoto RB, Queiroz DC, Ribeiro AA, Ribeiro APDB, Saliba JW, Sato HI, Silva JDP, Silva NP, Faria NR, Teixeira SMR, da Fonseca FG, Fernandes APSM, Zauli DAG, Januario JN, de Oliveira JS, Iani FCDM, de Aguiar RS, de Souza RP. Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status. Virus Evol 2022; 8:veac064. [PMID: 35996592 PMCID: PMC9384558 DOI: 10.1093/ve/veac064] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 06/24/2022] [Accepted: 07/26/2022] [Indexed: 11/24/2022] Open
Abstract
The emergence and global dissemination of Severe Acute Respiratory Syndrome virus 2 (SARS-CoV-2) variants of concern (VOCs) have been described as the main factor driving the Coronavirus Disease 2019 pandemic. In Brazil, the Gamma variant dominated the epidemiological scenario during the first period of 2021. Many Brazilian regions detected the Delta variant after its first description and documented its spread. To monitor the introduction and spread of VOC Delta, we performed Polymerase Chain Reaction (PCR) genotyping and genome sequencing in ten regional sentinel units from June to October 2021 in the State of Minas Gerais (MG). We documented the introduction and spread of Delta, comprising 70 per cent of the cases 8 weeks later. Comparing the viral loads of the Gamma and Delta dominance periods, we provide additional evidence that the latter is more transmissible. The spread and dominance of Delta did not culminate in the increase in cases and deaths, suggesting that the vaccination may have restrained the epidemic growth. Analysis of 224 novel Delta genomes revealed that Rio de Janeiro state was the primary source for disseminating this variant in the state of MG. We present the establishment of Delta, providing evidence of its enhanced transmissibility and showing that this variant shift did not aggravate the epidemiological scenario in a high immunity setting.
Collapse
Affiliation(s)
- Paula L C Fonseca
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Filipe R R Moreira
- MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, Exhibition Rd, South Kensington, London SW7 2BX, UK
- Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Av. Carlos Chagas Filho 373, Cidade Universitaria, Rio de Janeiro 21941-902, Rio de Janeiro, Brazil
| | - Rafael M de Souza
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Natália R Guimarães
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Nara O Carvalho
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad/Faculdade de Medicina/Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Av. Prof. Alfredo Balena 189, Centro, Belo Horizonte 30130-100, Minas Gerais, Brazil
| | - Talita E R Adelino
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Hugo J Alves
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Luige B Alvim
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - Darlan S Candido
- Department of Zoology, University of Oxford, 11a Mansfield Rd, Oxford OX13SZ, UK
- Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar 470, Jardim América, São Paulo 05403000, São Paulo, Brazil
| | - Helena P Coelho
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Alana V B Costa
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Walyson C Costa
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Alex F de Carvalho
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Bruna W F de Faria
- Secretaria Municipal de Saúde de Belo Horizonte, Av. Afonso Pena 2336, Funcionários, Belo Horizonte 30130-040, Minas Gerais, Brazil
| | - Aline B de Lima
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - Eneida S de Oliveira
- Secretaria Municipal de Saúde de Belo Horizonte, Av. Afonso Pena 2336, Funcionários, Belo Horizonte 30130-040, Minas Gerais, Brazil
| | - Carolina S A de Souza
- Pan American Health Organization—PAHO, Av. Das Nações SEN, Asa Norte, Brasilia 70312970, Brazil
| | - Fernanda G de Souza
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Rillery C Dias
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Victor E V Geddes
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Igor P Godinho
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Alessandro L Gonçalves
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Karine L Lourenço
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Rubens D M Magalhães
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Frederico S V Malta
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - Eva L A Medeiros
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Rodovia Papa João Paulo II 4143. Edifício Minas Gerais, Cidade Administrativa, Serra verde, Belo Horizonte 31630900, Minas Gerais, Brazil
| | - Fernanda S Mendes
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad/Faculdade de Medicina/Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Av. Prof. Alfredo Balena 189, Centro, Belo Horizonte 30130-100, Minas Gerais, Brazil
| | - Pedro H B de P Mendes
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Cristiane P T B Mendonça
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - Andre L Menezes
- Secretaria Municipal de Saúde de Belo Horizonte, Av. Afonso Pena 2336, Funcionários, Belo Horizonte 30130-040, Minas Gerais, Brazil
| | - Diego Menezes
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Mariane T Menezes
- MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, Exhibition Rd, South Kensington, London SW7 2BX, UK
| | - Lucyene Miguita
- Departamento de Patologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Rennan G Moreira
- Centro de Laboratórios Multiusuários, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Renata B Peixoto
- Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Daniel C Queiroz
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| | - Adriana A Ribeiro
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Ana Paula de B Ribeiro
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Juliana W Saliba
- Pan American Health Organization—PAHO, Av. Das Nações SEN, Asa Norte, Brasilia 70312970, Brazil
| | - Hugo I Sato
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Joice do P Silva
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - Natiely P Silva
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad/Faculdade de Medicina/Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Av. Prof. Alfredo Balena 189, Centro, Belo Horizonte 30130-100, Minas Gerais, Brazil
| | - Nuno R Faria
- MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, Exhibition Rd, South Kensington, London SW7 2BX, UK
- Department of Zoology, University of Oxford, 11a Mansfield Rd, Oxford OX13SZ, UK
- Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar 470, Jardim América, São Paulo 05403000, São Paulo, Brazil
| | - Santuza M R Teixeira
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Flávio G da Fonseca
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Ana Paula S M Fernandes
- Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Rua Professor José Vieira de Mendonça 770, Engenho Nogueira, Belo Horizonte 31310260, Minas Gerais, Brazil
| | - Danielle A G Zauli
- Instituto Hermes Pardini, Av. das Nações 2448, Distrito Industrial, Vespasiano 33201003, Minas Gerais, Brazil
| | - José Nélio Januario
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad/Faculdade de Medicina/Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Av. Prof. Alfredo Balena 189, Centro, Belo Horizonte 30130-100, Minas Gerais, Brazil
| | - Jaqueline S de Oliveira
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Rodovia Papa João Paulo II 4143. Edifício Minas Gerais, Cidade Administrativa, Serra verde, Belo Horizonte 31630900, Minas Gerais, Brazil
| | - Felipe C de M Iani
- Fundacao Ezequiel Dias, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte 30510-010, Minas Gerais, Brazil
| | - Renato S de Aguiar
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
- Instituto D’OR de Pesquisa e Ensino, Rio de Janeiro 22281100, Rio de Janeiro, Brazil
| | - Renan P de Souza
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte 31270901, Minas Gerais, Brazil
| |
Collapse
|
10
|
Avetyan D, Hakobyan S, Nikoghosyan M, Ghukasyan L, Khachatryan G, Sirunyan T, Muradyan N, Zakharyan R, Chavushyan A, Hayrapetyan V, Hovhannisyan A, Mohamed Bakhash SA, Jerome KR, Roychoudhury P, Greninger AL, Niazyan L, Davidyants M, Melik-Andreasyan G, Sargsyan S, Nersisyan L, Arakelyan A. Molecular Analysis of SARS-CoV-2 Lineages in Armenia. Viruses 2022; 14:1074. [PMID: 35632815 PMCID: PMC9142918 DOI: 10.3390/v14051074] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Revised: 05/04/2022] [Accepted: 05/13/2022] [Indexed: 12/11/2022] Open
Abstract
The sequencing of SARS-CoV-2 provides essential information on viral evolution, transmission, and epidemiology. In this paper, we performed the whole-genome sequencing of SARS-CoV-2 using nanopore and Illumina sequencing to describe the circulation of the virus lineages in Armenia. The analysis of 145 full genomes identified six clades (19A, 20A, 20B, 20I, 21J, and 21K) and considerable intra-clade PANGO lineage diversity. Phylodynamic and transmission analysis allowed to attribute specific clades as well as infer their importation routes. Thus, the first two waves of positive case increase were caused by the 20B clade, the third peak caused by the 20I (Alpha), while the last two peaks were caused by the 21J (Delta) and 21K (Omicron) variants. The functional analyses of mutations in sequences largely affected epitopes associated with protective HLA loci and did not cause the loss of the signal in PCR tests targeting ORF1ab and N genes as confirmed by RT-PCR. We also compared the performance of nanopore and Illumina short-read sequencing and showed the utility of nanopore sequencing as an efficient and affordable alternative for large-scale molecular epidemiology research. Thus, our paper describes new data on the genomic diversity of SARS-CoV-2 variants in Armenia in the global context of the virus molecular genomic surveillance.
Collapse
Affiliation(s)
- Diana Avetyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
| | - Siras Hakobyan
- Bioinformatics Group, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia;
- Armenian Bioinformatics Institute, Yerevan 0014, Armenia;
| | - Maria Nikoghosyan
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
- Bioinformatics Group, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia;
| | - Lilit Ghukasyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
| | - Gisane Khachatryan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
| | - Tamara Sirunyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
| | - Nelli Muradyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
| | - Roksana Zakharyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
| | - Andranik Chavushyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Davidyants Laboratories, Yerevan 0054, Armenia
| | - Varduhi Hayrapetyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
| | - Anahit Hovhannisyan
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
- Laboratory of Evolutionary Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia
| | - Shah A. Mohamed Bakhash
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98102, USA; (S.A.M.B.); (K.R.J.); (P.R.); (A.L.G.)
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Keith R. Jerome
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98102, USA; (S.A.M.B.); (K.R.J.); (P.R.); (A.L.G.)
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Pavitra Roychoudhury
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98102, USA; (S.A.M.B.); (K.R.J.); (P.R.); (A.L.G.)
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Alexander L. Greninger
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98102, USA; (S.A.M.B.); (K.R.J.); (P.R.); (A.L.G.)
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Lyudmila Niazyan
- NORK Infection Clinical Hospital, MoH RA, Yerevan 0047, Armenia; (L.N.); (M.D.)
| | - Mher Davidyants
- NORK Infection Clinical Hospital, MoH RA, Yerevan 0047, Armenia; (L.N.); (M.D.)
| | - Gayane Melik-Andreasyan
- National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan 0025, Armenia; (G.M.-A.); (S.S.)
| | - Shushan Sargsyan
- National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan 0025, Armenia; (G.M.-A.); (S.S.)
| | - Lilit Nersisyan
- Armenian Bioinformatics Institute, Yerevan 0014, Armenia;
- SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Solna, Sweden
| | - Arsen Arakelyan
- Laboratory of Human Genomics, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia; (L.G.); (G.K.); (T.S.); (N.M.); (R.Z.); (A.C.); (V.H.)
- Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia; (M.N.); (A.H.)
- Bioinformatics Group, Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia;
- Armenian Bioinformatics Institute, Yerevan 0014, Armenia;
| |
Collapse
|